Laura Bohn

14.0k total citations · 4 hit papers
117 papers, 9.4k citations indexed

About

Laura Bohn is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Laura Bohn has authored 117 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 94 papers in Cellular and Molecular Neuroscience and 17 papers in Pharmacology. Recurrent topics in Laura Bohn's work include Receptor Mechanisms and Signaling (84 papers), Neuropeptides and Animal Physiology (70 papers) and Pharmacological Receptor Mechanisms and Effects (27 papers). Laura Bohn is often cited by papers focused on Receptor Mechanisms and Signaling (84 papers), Neuropeptides and Animal Physiology (70 papers) and Pharmacological Receptor Mechanisms and Effects (27 papers). Laura Bohn collaborates with scholars based in United States, China and Italy. Laura Bohn's co-authors include Marc G. Caron, Raul R. Gainetdinov, Robert J. Lefkowitz, Kirsten M. Raehal, Cullen L. Schmid, Fang‐Tsyr Lin, Julia K. L. Walker, Richard T. Premont, Karsten Peppel and Chad E. Groer and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Laura Bohn

115 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2

1999 830 citations Laura Bohn, Robert J. Lefkowitz et al. profile →
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence

2000 753 citations Laura Bohn, Raul R. Gainetdinov et al. Nature profile →
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS

2004 672 citations Raul R. Gainetdinov, Richard T. Premont et al. profile →
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

2017 372 citations Cullen L. Schmid, Nicole Kennedy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Bohn United States	51	6.9k	6.8k	1.6k	664	443	117	9.4k
Susanna Cotecchia Switzerland	55	6.3k 0.9×	9.4k 1.4×	1.4k 0.9×	391 0.6×	225 0.5×	137	11.8k
Frederick J. Monsma United States	47	8.9k 1.3×	8.0k 1.2×	1.7k 1.1×	544 0.8×	226 0.5×	83	13.0k
Aline Dumuis France	54	5.2k 0.8×	5.0k 0.7×	891 0.6×	651 1.0×	155 0.3×	98	7.7k
Tangui Maurice France	58	4.7k 0.7×	7.0k 1.0×	2.0k 1.3×	1.9k 2.9×	572 1.3×	206	11.6k
Agata Copani Italy	54	4.0k 0.6×	4.0k 0.6×	3.3k 2.1×	946 1.4×	302 0.7×	117	8.6k
Lee‐Yuan Liu‐Chen United States	46	4.3k 0.6×	4.1k 0.6×	1.3k 0.8×	322 0.5×	98 0.2×	152	6.2k
Girolamo Calò Italy	52	7.5k 1.1×	6.2k 0.9×	2.9k 1.9×	546 0.8×	135 0.3×	322	9.7k
Lawrence Toll United States	40	4.5k 0.7×	4.4k 0.6×	1.7k 1.1×	378 0.6×	80 0.2×	148	6.2k
Kenneth P. Minneman United States	49	4.7k 0.7×	6.4k 0.9×	2.0k 1.3×	451 0.7×	105 0.2×	141	9.3k
Mark R. Brann United States	49	6.4k 0.9×	7.8k 1.2×	640 0.4×	510 0.8×	163 0.4×	112	10.3k

Countries citing papers authored by Laura Bohn

Since Specialization

Citations

This map shows the geographic impact of Laura Bohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bohn more than expected).

Fields of papers citing papers by Laura Bohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bohn. The network helps show where Laura Bohn may publish in the future.

Co-authorship network of co-authors of Laura Bohn

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bohn. A scholar is included among the top collaborators of Laura Bohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bohn. Laura Bohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quốc, Vương Đặng, Anastasiia Sadybekov, Laura Bohn, et al.. (2025). Exceptionally Potent Chiral Anandamide Analogs. Journal of Medicinal Chemistry. 68(23). 25061–25077.

Hua, Tian, Kiran Vemuri, Spyros P. Nikas, et al.. (2025). Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature. 646(8085). 754–758. 1 indexed citations

Quốc, Vương Đặng, Anastasiia Sadybekov, Suthakar Ganapathy, et al.. (2025). Novel Tetraolefinic Chain Phenyl Substituted Endocannabinoid Probes. Journal of Medicinal Chemistry. 68(13). 13376–13392. 1 indexed citations

Bohn, Laura & Edward L. Stahl. (2025). Characterization of the GTPγS release function of a G protein-coupled receptor. Nature Communications. 16(1). 11193–11193. 1 indexed citations

Quốc, Vương Đặng, Edward L. Stahl, Jo‐Hao Ho, et al.. (2024). Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site Mutations. PubMed. 3(3). 380–396. 2 indexed citations

Kolb, Peter, Terry Kenakin, S P H Alexander, et al.. (2022). Community guidelines for GPCR ligand bias: IUPHAR review 32. British Journal of Pharmacology. 179(14). 3651–3674. 121 indexed citations

Papanastasiou, Ioannis, Christos Iliopoulos‐Tsoutsouvas, Carol A. Paronis, et al.. (2021). Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists. European Journal of Medicinal Chemistry. 230. 114027–114027. 6 indexed citations

Grim, Travis W., Cullen L. Schmid, Nicole Kennedy, et al.. (2020). Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain. Neuropharmacology. 185. 108439–108439. 20 indexed citations

Grim, Travis W., Cullen L. Schmid, Edward L. Stahl, et al.. (2019). A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal. Neuropsychopharmacology. 45(2). 416–425. 59 indexed citations

10.

Brust, Tarsis F., Jenny Morgenweck, Susy A. Kim, et al.. (2016). Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Science Signaling. 9(456). ra117–ra117. 177 indexed citations

11.

Morgenweck, Jenny, Kevin J. Frankowski, Thomas E. Prisinzano, Jeffrey Aubé, & Laura Bohn. (2015). Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus. Neuropharmacology. 99. 600–609. 40 indexed citations

12.

Zhou, Hao, Mariangela Chisari, Kirsten M. Raehal, et al.. (2012). GIRK channel modulation by assembly with allosterically regulated RGS proteins. Proceedings of the National Academy of Sciences. 109(49). 19977–19982. 37 indexed citations

13.

Tarselli, Michael A., Kirsten M. Raehal, John M. Streicher, et al.. (2011). Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. Nature Chemistry. 3(6). 449–453. 52 indexed citations

14.

Lamb, Kenneth, Kevin Tidgewell, Denise S. Simpson, Laura Bohn, & Thomas E. Prisinzano. (2011). Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence. 121(3). 181–188. 53 indexed citations

15.

Béguin, Cécile, Justin S. Potuzak, Wei Xu, et al.. (2011). Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. Bioorganic & Medicinal Chemistry Letters. 22(2). 1023–1026. 22 indexed citations

16.

Raehal, Kirsten M. & Laura Bohn. (2010). The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology. 60(1). 58–65. 155 indexed citations

17.

Schmid, Cullen L. & Laura Bohn. (2010). Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo. Journal of Neuroscience. 30(40). 13513–13524. 136 indexed citations

18.

Xu, Heng, John S. Partilla, Xiaoying Wang, et al.. (2006). A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) μ‐opioid agonists on cellular markers related to opioid tolerance and dependence. Synapse. 61(3). 166–175. 45 indexed citations

19.

Bohn, Laura, Raul R. Gainetdinov, Fang‐Tsyr Lin, Robert J. Lefkowitz, & Marc G. Caron. (2000). μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature. 408(6813). 720–723. 753 indexed citations breakdown →

20.

Gainetdinov, Raul R., Laura Bohn, Julia K. L. Walker, et al.. (1999). Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice. Neuron. 24(4). 1029–1036. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact